Similarly, increased tumorigenesis capabilities in FN-treated NSCLC cells were observed in vivo (Fig. 1F), suggesting that FN could regulate NSCLC progression, leading to increased cell proliferation and tumorigenesis. The gene discussed is FN1; the disease is non-small cell lung carcinoma.